← Evidence map

ArticleCancers2021

Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer.

Soichiro Shimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34680299